Delivering quality for the measurement of immunosuppressive drugs: current performance and future needs

被引：5

作者：

Holt, DW ^{[1
]}

Johnston, A

机构：

[1] Univ London St Georges Hosp, Sch Med, Analyt Unit, London SW17 0RE, England

[2] St Bartholomews & Royal London Sch Med & Dent, London EC1M 6BQ, England

来源：

ACCREDITATION AND QUALITY ASSURANCE | 1999年 / 4卷 / 9-10期

关键词：

drugs proficiency testing; analytical quality indicators; calibrator material; traceability;

D O I：

10.1007/s007690050402

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

Whilst it is generally agreed that measurement of immunosuppressive drugs is of value as a guide to therapy, there are a number of problems associated with the analytical techniques available. Proficiency testing schemes enable laboratories to judge their performance for the measurement of these drugs with their peers. However, current schemes only compare accuracy within methods to document performance. This paper summarizes current findings and points out the limitations of our own schemes, and the measures we intend to use to address these deficiencies.

引用

页码：427 / 430

页数：4

共 14 条

[1] External quality assurance [J].

Hirst, AD .

ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 :12-18

[2] CYCLOSPORINE-A - ANALYTICAL METHODOLOGY AND FACTORS AFFECTING THERAPEUTIC DRUG-MONITORING [J].

HOLT, DW ;

JOHNSTON, A .

THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :625-630

[3] METHODOLOGICAL AND CLINICAL ASPECTS OF CYCLOSPORINE MONITORING - REPORT OF THE ASSOCIATION OF CLINICAL BIOCHEMISTS TASK-FORCE [J].

HOLT, DW ;

JOHNSTON, A ;

ROBERTS, NB ;

TREDGER, JM ;

TRULL, AK .

ANNALS OF CLINICAL BIOCHEMISTRY, 1994, 31 :420-446

[4] Cyclosporin microemulsion - A guide to usage and monitoring [J].

Holt, DW ;

Johnston, A .

BIODRUGS, 1997, 7 (03) :175-197

[5]

HOLT DW, 1998, LIGAND ASSAY, V3, P2

[6] CONCENTRATION-CONTROLLED TRIALS - WHAT DOES THE FUTURE HOLD [J].

JOHNSTON, A ;

HOLT, DW .

CLINICAL PHARMACOKINETICS, 1995, 28 (02) :93-99

[7] THE UNITED-KINGDOM CYCLOSPORINE QUALITY ASSESSMENT SCHEME [J].

JOHNSTON, A ;

MARSDEN, JT ;

HOLT, DW .

THERAPEUTIC DRUG MONITORING, 1986, 8 (02) :200-204

[8]

JOHNSTON A, 1993, CLIN CHEM, V39, P2532

[9] Therapeutic drug monitoring of cyclosporine and tacrolimus [J].

Oellerich, M ;

Armstrong, VW ;

Schütz, E ;

Shaw, LM .

CLINICAL BIOCHEMISTRY, 1998, 31 (05) :309-316

[10] LAKE-LOUISE-CONSENSUS-CONFERENCE ON CYCLOSPORINE ONITORING IN ORGAN-TRANSPLANTATION - REPORT OF THE CONSENSUS PANEL [J].

OELLERICH, M ;

ARMSTRONG, VW ;

KAHAN, B ;

SHAW, L ;

HOLT, DW ;

YATSCOFF, R ;

LINDHOLM, A ;

HALLORAN, P ;

GALLICANO, K ;

WONIGEIT, K ;

SCHUTZ, E ;

SCHRAN, H ;

ANNESLEY, T .

THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :642-654

← 1 2 →